Globus Medical (GMED)
(Delayed Data from NYSE)
$69.10 USD
-1.00 (-1.43%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $69.08 -0.02 (-0.03%) 6:56 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Brokerage Reports
Globus Medical, Inc. [GMED]
Reports for Purchase
Showing records 1 - 20 ( 162 total )
Company: Globus Medical, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Globus Medical, Inc.
Industry: Medical - Instruments
Company: Globus Medical, Inc.
Industry: Medical - Instruments
Company: Globus Medical, Inc.
Industry: Medical - Instruments
Company: Globus Medical, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Globus Medical, Inc.
Industry: Medical - Instruments
Company: Globus Medical, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Globus Medical, Inc.
Industry: Medical - Instruments
Company: Globus Medical, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Globus Medical, Inc.
Industry: Medical - Instruments
Company: Globus Medical, Inc.
Industry: Medical - Instruments
Company: Globus Medical, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Globus Medical, Inc.
Industry: Medical - Instruments
Company: Globus Medical, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Globus Medical, Inc.
Industry: Medical - Instruments
Company: Globus Medical, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Globus Medical, Inc.
Industry: Medical - Instruments
Company: Globus Medical, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Globus Medical, Inc.
Industry: Medical - Instruments
Company: Globus Medical, Inc.
Industry: Medical - Instruments
As Pre-Reported, but Still Early Stages On NUVA Merger
Provider: Roth Capital Partners, Inc.
Analyst: WHITE J